Location: Home > Pharma China Web Edition
  • search
  • go
  • News
  • 10/17/2025Recent Executive Moves
  • 10/17/2025LEO Pharma's Anzupgo Cream NDA Accepted in China
  • 10/17/2025Gilead's Kite Strikes Up to $1.64B In Vivo CAR-T Deal with China's Pre...
  • 10/17/2025RemeGen's Telitacicept Demonstrates Strong Phase 3 Efficacy in Lupus, ...
  • 10/17/2025Dianthus Secures Exclusive Global Rights to DNTH212 from China's Leads...
  • 10/17/2025Roche Expands Oncology Pipeline Thru Global Licensing Deal with Hansoh...
  • 10/17/2025I-Mab to Rebrand as NovaBridge Biosciences and Pursue Hong Kong IPO
  • 10/16/2025NHC Holds High-Level Meetings with Abbott and Roche to Advance Healthc...
  • 10/16/2025China NMPA Cancels 80 Drug Registration Certificates, Including Lorata...
  • 10/16/2025Belite Bio Secures Priority Review from China's NMPA for Tinlarebant
  • 10/16/2025Kailera Launches with $600M Series B to Advance GLP-1 Portfolio Acqui...
  • 10/16/2025Xuanzhu Bio Soars on Hong Kong Debut After Highly Oversubscribed IPO
  • 10/16/2025Qilu Presents Promising Phase I Data for AR PROTAC Degrader QLH12016
  • 10/15/2025Sino Biopharma's TQB2102 Receives Breakthru Therapeutic Designation in...
  • 10/15/2025Pfizer CEO Calls for Greater U.S.–China Collaboration in Biopharma In...
  • 10/14/2025GSK's Shingrix Wins Chinese Approval for Expanded Use
  • 10/14/2025Biokin and SystImmune Present Promising Early Data for EGFR×HER3 Bisp...
  • 10/14/2025Multitude Reports Updated Safety and Dose Findings for AMT-116 at ESMO...
  • 10/14/2025AskBio Reports Promising Safety Results from First Cohort of AB-1003 G...
  • 10/13/2025Huadao Secures Over CNY 100M in Series D+2 Financing to Advance CAR-T ...
  • 10/13/2025Lepu Reports Early Clinical Data for ADC Programs in Various Cancers
  • 10/13/2025Hansoh Pharma Reports Phase II Data for Oral B7H3 ADC HS-20093
  • 10/13/2025Lundbeck's Epilepsy Drug Bexicaserin Granted Breakthrough Therapy Stat...
  • 10/13/2025Two Decades of Pediatric Drug Trials in China Reveal Progress and Pers...
  • 10/13/2025CDE Seeks Input on Draft Technical Requirements for Sodium Iodide [131...
  • 10/13/2025CDE Solicits Comments on Draft Guidelines for Bioequivalence Risk Asse...
  • 10/13/2025CDE Issues Guidance to Address Common Challenges in Pediatric Drug Dev...
  • 10/13/2025China Introduces New Regulations to Govern Clinical Research and Appli...
  • 10/13/2025AviadoBio and UgeneX Enter Exclusive Option-License Deal to Develop Op...
  • 10/13/2025Huadao Bio Secures Over CNY 100M in Series D+2 Financing
  • Page:10/58 Total number of articles:1720: [First][<<] [8] [9] [10] [11] [12] [>>] [End]
  • Site map | Contact Us | Links
  • © Wicon International Group